UBS raises Aptiv stock price target to $66 from $58

Published 02/05/2025, 17:50
UBS raises Aptiv stock price target to $66 from $58

Friday - UBS analysts have increased the price target for Aptiv PLC (NYSE:APTV) to $66.00, up from the previous target of $58.00, while maintaining a Neutral rating on the stock. Currently trading at $59.29 with a market capitalization of $13.59 billion, InvestingPro analysis suggests the stock is undervalued, with five analysts recently revising their earnings estimates upward. The adjustment follows Aptiv’s first-quarter earnings for 2025, which surpassed expectations, along with a second-quarter EBIT/EPS forecast that is approximately 4/9% higher than consensus estimates. Additionally, the company has maintained its full-year guidance, despite consensus figures falling below the lower end of their forecast.

The updated price target takes into account the latest performance of Aptiv and incorporates the company’s tariff mitigation actions and recoveries. UBS has noted that while bears might argue the company’s full-year outlook doesn’t include the impact of tariffs and consider the lack of guidance for the second half of 2025 as a withdrawal or deferral of guidance, the firm believes such caution is acceptable and prudent given the circumstances.

According to UBS, the primary concern is not the tariffs themselves but the potential impact on volumes. The firm’s stance reflects the belief that the current uncertainty in the market warrants a conservative approach. Despite the challenges, Aptiv’s recent performance and forward-looking statements have provided a basis for the revised price target. The company’s attractive P/E ratio of 8.48 and beta of 1.64 suggest both value potential and market sensitivity. Discover more insights about Aptiv’s valuation metrics and growth potential with InvestingPro, which offers exclusive access to detailed financial analysis and real-time market intelligence.

Aptiv’s financial results and guidance indicate the company’s resilience in navigating the current economic landscape. The maintenance of full-year guidance, despite external pressures and market uncertainties, suggests a stable outlook for the company’s performance in the near term.

Investors and market watchers will continue to monitor Aptiv’s progress throughout the year, particularly regarding how the company manages potential volume impacts and further developments in tariff-related matters. UBS’s updated price target offers a perspective on the company’s valuation in light of these factors.

In other recent news, Aptiv PLC reported first-quarter earnings and revenue that exceeded expectations. The company achieved an adjusted earnings per share of $1.69, surpassing the analyst estimate of $1.51. Revenue for the quarter was $4.8 billion, slightly above the consensus forecast of $4.78 billion, although it marked a 2% year-over-year decline. Looking ahead, Aptiv has provided strong guidance for the second quarter, expecting earnings per share between $1.70 and $1.90 and revenue between $4.92 billion and $5.12 billion. The company also raised its full-year 2025 outlook, projecting earnings per share of $7.00 to $7.60 and revenue of $19.6 billion to $20.4 billion. Despite the revenue decline, Aptiv generated $273 million in cash from operations in the first quarter. The adjusted operating income margin was 11.9%, and the adjusted EBITDA margin was 15.7%. The company’s performance and guidance reflect its focus on operational excellence, according to CEO Kevin Clark.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.